Tower A-25-06, The Met Corporate Tower, Jalan Dutmas 2, Kompleks Kerajaan, 50480, Kuala Lumpur, Malaysia
+6018-4668533

About Tianjin Meihua

Tianjin Meihua Pharmaceutical Sales Co., Ltd. was established in 2012 as a wholly-owned subsidiary of Tianjin Meihua Pharmaceutical Co., Ltd., with a paid-up capital of 10 million RMB. The company obtained the new version of GSP certification on May 7, 2014, and received the certificate.

The primary business scope includes: traditional Chinese medicines, chemical raw materials, chemical pharmaceutical formulations, antibiotic raw materials, and antibiotic formulations.

tianjin_meihua_pharmaceutical_logo
tianjin_meihua_pharmaceutical

About Company

tianjin_meihua_pharmaceutical

The company boasts advanced
laboratory equipment, production
facilities, and a team of
specialized professionals
dedicated to new drug research.
Their expertise lies in the
development of respiratory drugs,
controlled-release technology,
flavor masking techniques for
pharmaceutical formulations, and
plant-based drug extraction.

Tianjin Meihua Pharmaceutical
primarily focuses on respiratory
system drugs and controlledrelease formulations. They hold
certifications for Good
Manufacturing Practices (GMP)
and Good Storage Practices
(GSP), as well as drug production
licenses and national approval
for various drug varieties.

The company has independent
research and development efforts
are concentrated on commonly
used respiratory drugs like
"Doxofylline Injection" and
"Aminophylline Hydrochloride
Injection,
" with several patents
pending for related technologies.
Their controlled-release
technology, exemplified by
"Gliclazide Controlled-Release
Capsules,
" is considered advanced
in China.

CERTIFICATE & AWARD

INTELLECTUAL PROPERTY

The company currently holds 17 granted invention patents, with 3 patents undergoing substantive examination, 18 utility model patents, 6 design patents, 16 trademarks, and 3 copyrights.

tianjin-cert-1
tianjin-cert-2
tianjin-cert-3
tianjin-cert-4
tianjin-cert-6
tianjin-cert-5
tianjin-cert-7

CERTIFICATE & AWARD

INTELLECTUAL PROPERTY

The company currently holds 17 granted invention patents, with 3 patents undergoing substantive examination, 18 utility model patents, 6 design patents, 16 trademarks, and 3 copyrights.

tianjin-cert-1
tianjin-cert-2
tianjin-cert-3
tianjin-cert-4
tianjin-cert
tianjin-cert-6
tianjin-cert-5
tianjin-cert-7